Trial intelligence / Profile preview

Mifepristone Tablets for Preoperative Treatment of Uterine Fibroids (Phase IV, China)

CTR20170282Phase 4Completed

Sponsor
China Resources Zizhu Pharmaceutical
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mifepristone in Fibromyoma (LM), sponsored by China Resources Zizhu Pharmaceutical. Started May 2017; status: completed.

02

Drugs

mifepristone
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on CTR20170282.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170282.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call